BioTek announces launch of Lionheart FX Automated Live Cell Imager

NewsGuard 100/100 Score

BioTek Instruments announces the launch of the Lionheart™ FX Automated Live Cell Imager with Augmented Microscopy™. Lionheart FX is optimized for kinetic live cell imaging, with up to 100x air and oil immersion magnification in a variety of slides, dishes, microplates and flasks. Imaging channels include brightfield, color brightfield, phase contrast and fluorescence, with both image-based and laser autofocus.

A unique environmental control cover provides convenience beyond that of typical digital microscopes, allowing for incubation up to 40º C and gas control, while the optional humidity chamber and dual reagent injectors enhance environmental support for live cell imaging workflows. Gen5™ 3.0 Software provides automated image capture and analysis, plus annotation and movie maker functions, offering ease and simplicity across a broad range of live and fixed cell applications. Augmented Microscopy is the combination of all of these features in one compact system. Lionheart FX is ideal for live and fixed cell applications including kinetic live cell assays, 3D spheroid imaging, translocation and colocalization studies, cell migration and invasion, proliferation, viability, toxicity and many more.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel immune cell therapy may be a promising strategy for combating HBV infection